Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 6/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 1.00 |
| ▸ | SNCA | P37840 | 5/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 1.00 |
| ▸ | MAPT | P10636 | 4/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 4/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 4/20 | 1.00 |
| ▸ | GAA | P10253 | 3/20 | 1.00 |
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | APEX1 | P27695 | 3/20 | 1.00 |
| ▸ | RECQL | P46063 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 3/20 | 1.00 |
| ▸ | PKM | P14618 | 2/20 | 1.00 |
| ▸ | ALPL | P05186 | 2/20 | 1.00 |
| ▸ | POLB | P06746 | 2/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 2/20 | 1.00 |
| ▸ | RAD52 | P43351 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (+)-Epicatechin SCHEMBL862089 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Cianidanol SCHEMBL1330653 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Catechin SCHEMBL10033927 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| (-)-Epicatechin SCHEMBL19412 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Cianidanol SCHEMBL12392372 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Cianidanol SCHEMBL13610161 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Catechin SCHEMBL19411 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Cianidanol SCHEMBL19741 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| Cianidanol SCHEMBL5081456 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 | |
| (-)-Catechin SCHEMBL166733 | 1.00 | BACE1 (1.00) | BACE1KDM4EHSD17B10SNCAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 302 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118103078-A | Stabilized compositions of radionuclides and uses thereof | 瑞择生物公司 | 2024-05-28 | — | — | CN | claimed |
| EP-0137832-B1 | PHARMACEUTICAL COMPOSITIONS OF ANTI-PANCREATIC INFLAMMATORY EFFECT | BIOGAL GYOGYSZERGYAR (HU) | 1987-08-12 | — | — | EP | claimed |
| JP-56016412-A | — | — | None | — | — | JP | disclosed |
| EP-4543959-B1 | SOLUTION OF POLYPHENOLS IN AMINE | SIKA TECH AG (CH) | 2026-05-13 | — | — | EP | disclosed |
| EP-4543959-A1 | SOLUTION OF POLYPHENOLS IN AMINE | Sika Technology AG (CH) | 2025-04-30 | — | — | EP | disclosed |
| CN-118103078-A | Stabilized compositions of radionuclides and uses thereof | 瑞择生物公司 | 2024-05-28 | — | — | CN | disclosed |
| WO-2023247445-A1 | SOLUTION OF POLYPHENOLS IN AMINE | SIKA TECHNOLOGY AG (CH) | 2023-12-28 | — | — | WO | disclosed |
| EP-4296291-A1 | SOLUTION OF POLYPHENOLS IN AMINE | Sika Technology AG (CH) | 2023-12-27 | — | — | EP | disclosed |
| US-20230310461-A1 | Compositions and Methods for Treatment of Prediabetes | CROSS III WILLIAM H (US) | 2023-10-05 | — | — | US | disclosed |
| US-20230310461-A1 | Compositions and Methods for Treatment of Prediabetes | CROSS III WILLIAM H (US) | 2023-10-05 | — | — | US | disclosed |
| WO-2023117847-A1 | USE OF CATECHIN FOR THE TREATMENT OF FGFR-RELATED BONE REPAIR AND BONE FORMATION IMPAIRMENT | INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) | 2023-06-29 | — | — | WO | disclosed |
| EP-0065123-B1 | HARDLY SOLUBLE SALTS OF AMINOGLYCOSIDE ANTIBIOTICS | MERCK PATENT GmbH (DE) | 1984-07-25 | — | — | EP | disclosed |
| US-4461907-A | Amino-substituted flavans useful as anti-viral agents | BURROUGHS WELLCOME CO. | 1984-07-24 | — | — | US | disclosed |
| EP-0065123-A1 | Hardly soluble salts of aminoglycoside antibiotics | MERCK PATENT GmbH (DE) | 1982-11-24 | — | — | EP | disclosed |
| EP-0004579-B1 | FLAVANS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-08-18 | — | — | EP | disclosed |
| EP-0051061-A2 | Novel intermediates and process for their preparation | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-05-05 | — | — | EP | disclosed |
| US-4285964-A | AMINE SALTS OF LYSINE OR ARGININE; BONE DISORDERS; JOINTS; CONNECTIVE TISSUE; ANTIINFLAMMATORY AGENTS; SOLUBILITY | CONTINENTAL PHARMA (BE) | 1981-08-25 | — | — | US | disclosed |
| US-4268517-A | (+)-CATECHIN | CONTINENTAL PHARMA (BE) | 1981-05-19 | — | — | US | disclosed |
| JP-S5616412-A | CARCINOSTATIC AGENT | KANEBO LTD | 1981-02-17 | — | — | JP | disclosed |
| EP-0004579-A1 | Flavans, process for their preparation and pharmaceutical compositions containing them | THE WELLCOME FOUNDATION LIMITED (GB) | 1979-10-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230310461-A1 | Compositions and Methods for Treatment of Prediabetes | GPX1, GPX4, NFE2L2 | BACE1 1069/4885KDM4E 4445/4885HSD17B10 210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.